Increasing funding from public and private sector bodies for developing new products and support for promoting live cell encapsulation systems is a key factor fueling growth of the live cell encapsulation market
The global live cell encapsulation market size is expected to reach USD 350 million by 2028 and register a CAGR of 3.6%, according to the latest report by Reports and Data. Factors driving global market revenue growth are rising prevalence of target diseases and latest technological advancements in cell encapsulation techniques.
Live cell encapsulation is one of the most convincing approaches for treating various target diseases. It is a technology that encloses live cells in protective capsules that are equal to size of a headpin. Essential nutrients and blood are allowed to flow through the capsules in order to provide nourishment to the living cell. Capsule acts as a protective barrier to protect the cells from patient’s immune system. Market growth is driven by factors, such as increasing awareness regarding significance of using live cell encapsulation for treating target diseases and rising investments by market players to develop new products and techniques and enhance their product line.
Unavailability of good quality raw materials, unaffordable prices for manufacturing of products, and accessibility to affordable alternative therapies are some key restraints expected to impede growth of the live cell encapsulation market. Moreover, lack of trained professionals for operating these modern techniques is expected to limit market growth during the forecast period.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC])@ https://www.reportsanddata.com/sample-enquiry-form/4018
Growth in the historic period resulted from the rapid growth in the elderly population, strong economic growth in emerging markets, decline in oil prices, and health insurance reforms globally. Factors that negatively affected growth in the historic period were low healthcare access, shortages of skilled human resources, difficulty in manufacturing biologics, and regulatory changes.
Going forward, faster economic growth, technological developments and the increasing prevalence of diseases due to rising busy and sedentary lifestyles will drive the growth. Factors that could hinder the growth of this market in the future are rising interest rates, increasing awareness of alternative therapies and natural remedies, government provisions in healthcare services, and stringent government regulations.
North America is the largest market for healthcare, followed by Asia-Pacific, Western Europe and then the other regions. Due to favorable regulations and policies in these regions, healthcare industry is rapidly growing. As the market in developed countries is nearly saturated, market players have shifted their focus toward the developing regions, especially the emerging economies of Asia Pacific.
Order this Reports @ https://www.reportsanddata.com/report-pricing/4018
The prominent factors favoring market growth include increasing launches and initiatives by the market players to provide rapid treatment for addressing the diseases of the patients in the healthcare industry. Market-trend-based strategies for the healthcare market include increasing the adoption of bundled payments, using digital tools, increasing collaborations across industries and companies, focusing on the development of new medicines, and adopting hybrid imaging technology. Players adopted strategies in the healthcare industry include acquiring companies in similar industries to expand their presence and focusing on offering quality products and services.
The competitive landscape section of the report discusses in detail the company overview, product and services portfolio, business expansion plans, production and manufacturing capacity, financial standing, and global market position. It further sheds light on the recent mergers and acquisitions, collaborations, partnerships, corporate and government deals, agreements, and product launches.
Top companies operating in the market and profiled in the report include:
BioTime, Inc. (US), Viacyte, Inc. (US), and Living Cell Technologies Ltd. (Australia) are the top three players in the live cell encapsulation market. Other prominent players operating in this market include Sigilon Therapeutics, Inc. (US), Evonik Industries (Germany), BÜCHI Labortechnik AG (Germany), Blacktrace Holdings Ltd (UK), and Sernova Corporation (Canada), Neurotech Pharmaceuticals, Inc. (US), Gloriana Therapeutics (US), Kadimastem (Israel), Beta-O2 Technologies, Inc. (Israel), Defymed (France), and Altucell, Inc. (US).
Further, the report segments the Live Cell Encapsulation market on the basis of product types, applications, end-use industries, and technology among others. The report offers insights into key factors influencing the revenue growth of the segment and provides information about lucrative investment opportunities to stakeholders, investors, and clients.
Live Cell Encapsulation Market Segmentation:
Based On Manufacturing Technique (Revenue, USD Million, 2018 - 2028)
- Simple Dripping
- Electrostatic Dripping
- Liquid Jet Break Up
- Coaxial Airflow
- Vibrating Jet
- Jet Cutting
- Rotating Disk Atomization
Based On Polymer Type (Revenue, USD Million, 2018 - 2028)
- Siliceous Encapsulates
- Cellulose Sulfate
- Other Polymers
Based On Application (Revenue, USD Million, 2018 - 2028)
- Drug Delivery
- Regenerative medicine
- Cell Transplantation
Regional Analysis covers:
- North America
- Rest of EU
- Asia Pacific
- South Korea
- Rest of APAC
- Latin America
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of MEA
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/4018
Thank you for reading our report. To know more about the customization feature, please get in touch with us and our team will ensure the report is customized to meet your requirements.
Explore More Industry Research by Reports and Data:
Herpes Simplex Treatment Market @ https://www.biospace.com/article/increase-in-demand-for-appropriate-treatment-for-rare-diseases-is-expected-to-drive-herpes-simplex-treatment-market-revenue-growth-by-2030-says-reports-and-data/
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370